Medications for Urticaria

46 results
Foxland Pharmaceuticals, Inc.
Usage: Carbinoxamine maleate is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, dermatographism, and as an adjunct therapy for anaphylactic reactions after acute symptoms have been controlled. It also helps reduce allergic reaction severity to blood or plasma.
Genus Lifesciences
Usage: Clemastine Fumarate Tablets USP, 2.68 mg are indicated for relieving symptoms of allergic rhinitis (sneezing, runny nose, itching, tearing) and mild, uncomplicated allergic skin reactions such as urticaria and angioedema, specifically at the 2.68 mg dosage.
Boscogen, Inc.
Usage: The drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin manifestations (urticaria and angioedema), cold urticaria, dermatographism, and as adjunctive therapy for anaphylactic reactions following initial treatment.
VistaPharm, LLC
Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions (urticaria and angioedema), ameliorating allergic reactions to blood or plasma, cold urticaria, and dermatographism. It is also used as adjunctive therapy for anaphylactic reactions.
Rising Pharma Holdings, Inc.
Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, ameliorating allergic reactions to blood, and as an adjunctive therapy for anaphylactic reactions after acute management.
Patrin Pharma, Inc.
Usage: The drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, and as an adjunctive therapy for anaphylactic reactions after initial treatment with epinephrine and standard measures.
Amneal Pharmaceuticals of New York LLC
Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, amelioration of allergic reactions to blood, cold urticaria, dermatographism, and as an adjunctive therapy for anaphylactic reactions after initial management.
Mylan Institutional LLC
Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.
Amneal Pharmaceuticals LLC
Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, allergic states, gastrointestinal diseases, respiratory diseases, hematologic disorders, and certain dermatologic and ophthalmic diseases. It can be administered intravenously, intramuscularly, intra-articular, or intralesionally for acute episodes and management of chronic conditions.
Civica, Inc.
Usage: This drug is indicated for various conditions, including endocrine disorders (like adrenocortical insufficiency), rheumatic and collagen diseases, severe allergic reactions, dermatologic and gastrointestinal diseases, respiratory issues, hematologic conditions, neoplastic diseases, and neurological disorders. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally as appropriate.